Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on October 1, 2026

Oct. 1, 2026

GALEX AI Expands Patent-Pending Clinical Audit Technology for U.S. Hospitals

Indeterminate EIN Presswire

Oct. 1, 2026

Sanderson Settlement Solutions LLC Launches to Provide Strategic Settlement Services to the Insurance and P&C Industry

Indeterminate EIN Presswire

Oct. 1, 2026

Loyal Source Government Services Appoints Jen Marrion to Lead Growth Strategy and Market Intelligence

Indeterminate EIN Presswire

Oct. 1, 2026

New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program

Indeterminate GlobeNewswire

Oct. 1, 2026

Medicenna Announces Results of Annual General and Special Meeting of Shareholders

Indeterminate GlobeNewswire

Oct. 1, 2026

Wandercraft Acquires Ekso Bionics, Uniting Two Pioneers to Advance and Expand Robotic Mobility

Indeterminate GlobeNewswire

Oct. 1, 2026

VELA Medical highlights why Patient Positioning Matters in CBCT Scanning

Indeterminate EIN Presswire

Oct. 1, 2026

Digital Auxilius Joins SCRS 2026 Global Site Solutions Summit as Performance Sponsor

Indeterminate EIN Presswire

Oct. 1, 2026

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

Indeterminate GlobeNewswire

Oct. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Caribou Announces Leadership Transition: Richard Fleder to Become Executive Chairman; Amy Gasbarro Appointed CEO

Indeterminate EIN Presswire

Oct. 1, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Indeterminate GlobeNewswire

Oct. 1, 2026

Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier

Indeterminate GlobeNewswire

Oct. 1, 2026

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Indeterminate GlobeNewswire

Oct. 1, 2026

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation

Indeterminate GlobeNewswire

Oct. 1, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire